There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Oncoviruses are implicated in approximately 12% of all human cancers. A large number of
the world's population harbors at least one of these oncoviruses, but only a small proportion …

Liver cancer is the fifth most common cancer worldwide in men and the ninth in women. It is
also the second most common cause of cancer mortality. Hepatocellular carcinoma (HCC) is …

Chronic hepatitis B virus (HBV) and chronic hepatitis C virus (HCV) are associated with
hepatic fibrosis and development of hepatocellular carcinoma (HCC). There are differences …

Seven kinds of virus collectively comprise an important cause of cancer, particularly in less
developed countries and for people with damaged immune systems. Discovered over the …

Objective Due to long lag time between infection/cancer diagnoses human papillomavirus
(HPV) vaccination programs will deliver vaccine efficacy (VE) estimates against cancer end …

Despite effective and safe hepatitis B virus (HBV) vaccine and antiviral therapies, HBV-
related hepatocellular carcinoma (HCC) remains a major cause of deaths in young adults in …

Hepatocellular carcinoma (HCC) is a common cancer worldwide and represents the
outcome of the natural history of chronic liver disease. The growing rates of HCC may be …

Background Preventing mother to child transmission of chronic hepatitis B infection in the
setting of a high maternal viral load is challenging. The idea has emerged from antepartum …

Hepatitis B virus (HBV) is a major cause of morbidity and mortality with a disproportionate
impact on Asia and Africa. Current guidelines recommend screening at-risk populations for …